This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Express Scripts Holding Company Announces Third Quarter 2013 Earnings Conference Call

ST. LOUIS, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its third quarter earnings on Thursday, October 24, 2013 after the market closes and will hold its quarterly conference call to discuss third quarter results on Friday, October 25, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

This call is being webcast and can be accessed at the Investor Information section of Express Scripts' web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.

A slide presentation will be posted on our website. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts' website for 14 days.

About Express Scripts

Express Scripts (Nasdaq:ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science SM, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

CONTACT: Matt Harper, Interim Chief Financial Officer
         David Myers, Vice President Investor Relations
         (314) 810-3115
         Investor.relations@express-scripts.com

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,092.65 +68.59 0.38%
S&P 500 2,117.74 +9.45 0.45%
NASDAQ 5,026.6220 +21.2310 0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs